ChemicalBook > Product Catalog >Analytical Chemistry >Standard >Pharmaceutical Impurity Reference Standards >Tofacitinib Impurity 3

Tofacitinib Impurity 3

Tofacitinib Impurity 3 Suppliers list
Company Name: TOSUN PHARM  
Tel: 020-61855200 13326451905
Email: 2881290884@qq.com
Products Intro: Product Name:Tofatinib Impurity 3
CAS:1206825-36-6
Purity:98%以上 Package:10mg;50mg;100mg等多种规格 Remarks:REF-T11033
Company Name: Hubei Moco Chemical Co., Ltd.  
Tel: 18627756402
Email: 3001051413@qq.com
Products Intro: Product Name:Tofacitinib IMpurity 3
CAS:1206825-36-6
Purity:95%+hplc Package:5mg/;15mg/;25mg/
Company Name: Jinan blalong chemical co. LTD  
Tel: 2710913286@.com
Email: 1513643261@qq.com
Products Intro: Product Name:TofacitinibImpurity3
CAS:1206825-36-6
Purity:99% HPLC Package:50G;10G;1G;500MG;100MG
Company Name: Shenzhen Hengfeng Wanda Pharmaceutical Technology Co., Ltd  
Tel: 755-22677922-801 18126518403
Email: 2851922760@qq.com
Products Intro: Product Name:Tofacitinib Impurity 3
CAS:1206825-36-6
Purity:98%HPLC Package:10mg/
Company Name: SHENZHEN PHYSTANDARD BIO-TECH CO.,LTD  
Tel: 0755-0755-0755-83725350 13380397412
Email: 3001280422@qq.com
Products Intro: Product Name:Tofacitinib Impurity 19
CAS:1206825-36-6
Purity:99% HPLC Package:10mg;25mg;50mg;100mg
Tofacitinib Impurity 3 Basic information
Product Name:Tofacitinib Impurity 3
Synonyms:7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-, rel-;Tofatinib Impurity 3
CAS:1206825-36-6
MF:C13H19N5
MW:245.32
EINECS:
Product Categories:
Mol File:1206825-36-6.mol
Tofacitinib Impurity 3 Structure
Tofacitinib Impurity 3 Chemical Properties
density 1?+-.0.06 g/cm3(Predicted)
pka13.36±0.50(Predicted)
Safety Information
MSDS Information
Tofacitinib Impurity 3 Usage And Synthesis
Tofacitinib Impurity 3 Preparation Products And Raw materials
Tag:Tofacitinib Impurity 3(1206825-36-6) Related Product Information
Tofacitinib Impurity 6 3-Amino-4-methylpyridine N-((3S,4S)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine Methyl (1-benzyl-4-Methylpiperidin-3-yl)carbaMate 13-Deoxyepirubicin 3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine 3-METHOXYCARBONYLAMINO-4-METHYLPYRIDINE 1-[2-(2-methoxyphenoxy)ethylamino]-3-(9-methylcarbazol-4-yl)oxypropan-2-ol:hydrochloride 7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-7-[(4-Met hylphenyl)sulfonyl]- Methyl (4-Methylpiperidin-3-yl)carbaMate 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile 4-CHLORO-7-TOSYL-7H-PYRROLO[2,3-D]PYRIMIDINE 3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI) (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride